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Assessing the adherence of obstetricians towards postpartum diabetes screening
guidelines: a pre- and post-intervention study at secondary care hospital in
Karachi, Pakistan
Sadiqa Munir Razzaqui1, Neelofur Babar2, Zaib-un-Nisa Memon3, Sarah Rafiq4
Introduction
Worldwide, diabetes mellitus (DM) is currently the fastest
growing non-communicable disease and has gained
epidemic levels.1 Gestational diabetes mellitus (GDM) is
a significant risk factor for the development of type 2
diabetes mellitus (T2DM). According to the American
Diabetes Association (ADA) GDM is "any degree of
glucose intolerance with the onset or first recognition
during pregnancy".2 GDM increases the risk of adverse
pregnancy consequences, including maternal and
perinatal mortality, obstructed labour, infections,
spontaneous abortion, congenital abnormalities and
macrosomia.3 Women with GDM are not only prone to
develop T2DM, but also have increased risk of
cardiovascular disease later in life.4,5 In addition, children
of women with GDM are at increased risk of obesity,
glucose intolerance, and overt diabetes mellitus (DM) in
adult life.6
The Fifth International Workshop-Conference on GDM
recommended intensive postpartum monitoring:
Random / fasting blood glucose (FBG) 1-3 days
postpartum; oral glucose tolerance test (OGTT) 6-12
weeks later, to be repeated 1 year postpartum and tri-
annually thereafter with annual FBG in between.7 Despite
these strategies, it has been noted that postpartum
screening rates are low among high-risk mothers and
range 23-58%.8,9
Women with GDM-affected pregnancy have a 20%
chance of developing T2DM in the first decade following
pregnancy though the risk can be as high as 70% in
higher risk populations.10,11 Postpartum screening for
DM allows for timely interventions to reduce the risk DM
as well as to carry out appropriate treatment of its
complications in affected women. One of the reasons
for low screening rates is failure of the obstetricians to
Abstract
Objective: To assess the adherence level of obstetricians towards postpartum diabetes screening
guidelines.
Methods: The quasi-experimental pre- and post-intervention study was conducted from May 2014
to April 2015 at Aga Khan Hospital for Women-Karimabad, Karachi, and comprised all obstetricians
practicing at the time. All the booked women with gestational diabetes delivered in the 6 months
before refresher lecture (group 1) and those delivering in the 6 months following the intervention
(group 2) were included. Data was analysed using SPSS 19.
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The intervention made it thrice likely (95% confidence interval: 7.83) that a physician advised
postpartum oral glucose tolerance test. Caesarean section increased the chances of getting test
advice almost 4 times (95% confidence interval: 1.70, 9.10) compared to women who delivered
vaginally. Women managed on insulin with / without metformin were 4 times likely to being advised
the test compared to women managed on diet (confidence interval: 1.00, 17.09). Full-time employees
advised 7 times more than the visiting obstetricians (confidence interval: 1.33, 35.16).
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detection of abnormal glucose tolerance in early postpartum period.
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advise appropriate test. To improve postpartum
screening, there is a need to introduce system factors
that facilitate adherence to guidelines.
The current study was planned to assess the adherence
of obstetricians to the recommended guidelines for
postpartum screening of GDM-affected women.
Subjects and Methods
The quasi-experimental pre- and post-intervention study
was conducted from May 2014 to April 2015 at Aga Khan
Hospital for Women-Karimabad (AKHW-K), Karachi, and
comprised all obstetricians practicing at the time.  It is
an outreach secondary care centre of Aga Khan University
Hospital (AKUH), Karachi, with a delivery rate around
3,000 per year. Institutional ethics review committee's
approval was taken. All women booked for delivery with
GDM diagnosed on the basis of FBG 92mg/dl at initial
visit and 75gm OGTT.
Diagnostic Reference Values for Gestational Diabetes
Fasting glucose: 92 mg/dl
1-hour glucose : 180 mg/dl
2-hour glucose : 153 mg/dl
Note: The diagnosis of Gestational Diabetes Mellitus (GDM) is made when any of
the above plasma glucose values are exceeded.
Reference: American Diabetic Association Diabetes Care, Jan 2012.35(S1):p.S64-SS71.
between 24 and 32 weeks of gestation were included.
Those who delivered in the 6 months before intervention
were designated as group 1, and those who delivered in
the 6 months after a refresher lecture formed group 2.
All obstetricians practising at the centre were assessed
for adherence to postpartum DM screening guidelines
by reviewing the medical records of patients.
GTT-2 Hrs Interpretation:
2-h post load glucose < 140 mg/dl= normal glucose tolerance.
2-h post load glucose 140-199 mg/dl= Impaired glucose tolerance
 2-h post load glucose > 200 mg/dl = Provisional diagnosis of diabetes.
Reference: American Diabetic Association (ADA) 2007
Refresher lecture on postpartum DM screening guidelines
was conducted on November 26, 2014, to create
awareness and refresh the knowledge. Labour record
management system (LRMS) was used to identify women
with GDM-affected pregnancy who delivered during the
study period. Prospective and retrospective review of
the medical records was done. Data was collected on a
pre-designed proforma. It included obstetrician's
employment status and experience in years. Patient data
included age, parity, GDM history, antenatal treatment
of GDM (diet control or drug therapy: metformin ±
insulin), family history of diabetes, outcome of pregnancy
(livebirth or stillbirth), mode of delivery (vaginal or
operative), baby's weight, and OGTT laboratory report.
The outcome examined was documented plan of
postpartum DM screening in the medical record of
women with GDM-affected pregnancy at their 1st
postnatal (PN) visit between 1st and 2nd PN weeks. The
records were again reviewed at 6-12 weeks postpartum,
allowing sufficient time to complete postpartum OGTT
and postpartum follow-up visit. These records were
examined for documentation of OGTT at 1st PN visit,
and availability of OGTT report at 6 weeks PN visit.
After initial review of the records and collection of data,
the intervention in the shape of the refresher lecture on
postpartum DM screening guideline was delivered. The
records were reviewed 6 months later for post-
intervention review which was done on the same pattern
as the pre-intervention data. Data was analysed using
SPSS 19 December 2, 2016, to October 5, 2017.
Results
Of the 550 cases, 275(50%) each were in groups 1 and
2. All pregnant women had live-birth. A total of 352(64%)
women were aged <30 and 327(59.5%) were multiparous.
There was no statistical difference between the groups
in terms of age, parity, gestational age at delivery and
GDM history (p>0.05 each) (Table 1).
Logistic regression showed that intervention made it
thrice likely (Adjusted odds ratio [AOR]: 3.34; 95%
confidence interval [CI]" 1.43, 7.83) for the physicians to
advise postpartum OGTT. Caesarean section (CS) also
increased the chances of getting advised for OGTT almost
4 times (AOR: 3.94; 95% CI: 1.70, 9.10) compared to
women who delivered vaginally. Women managed on
insulin with / without metformin were 4 times likely to
get advised for OGTT compared to women managed on
diet (AOR: 4.14; 95% CI: 1.00, 17.09). Full-time employees
advised OGTT 7 times more than the visiting obstetricians
(Table 2).
Discussion
Studies have shown that identification of pre-diabetes
is important since up to 70% of these individuals
eventually develop T2DM.12 Therefore abnormal glucose
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homeostasis antenatally poses increased risk of future
DM.13
The current study found that during the pre-intervention
period, 27.6% women with GDM received a documented
order for postpartum OGTT which increased to 50.9%
post-intervention. Although the obstetricians' rate of
advising postpartum OGTT increased, the overall rate
still remained low.
Several factors were noted during the study that
influenced postpartum OGTT advice.
Women with GDM who had CS were four times more
likely to get advice for OGTT testing compared to women
who delivered vaginally as almost all these women had
1st postoperative visit for the removal of stitches.
Also, it was evident that GDM women who were treated
with metformin alone, metformin-and-insulin or insulin
alone were given requisition for postpartum OGTT
testing. Several studies have shown similar effect,14 while
other s tudies  have shown cont rar y  resul t .1 5
One of the reasons that patients were not advised
postpartum OGTT seemed to be that patients did not
return for follow-up.  Other studies16 also showed that
attendance at postpartum clinics was a very important
factor in glucose testing. This calls for looking into the
factors leading to non-compliance on the part of the
patients as well.
Interestingly, it was found that full-time faculty was more
compliant towards DM screening guidelines
compared to the visiting obstetricians, and the
rate of advising GTT increased significantly after
intervention.
Another factor is that though obstetricians
advised OGTT, patients had it performed at
another laboratory outside our centre whose
results may or may not be available in medical
records.
The current study has its limitations as it was
only a medical chart review and, therefore, it
could not determine whether defects in testing
were attributable to patients, physicians or
healthcare system barriers; or to all three
combined. Also, since it is a single-centre study,
the findings are not generalisable.
Conclusion
Adherence of obstetrician to postpartum DM screening
guidelines improved after intervention, but overall rate
of postpartum DM screening was still low. Apart from
encouraging the physicians, there is also a need for
educating the patients in this regard.
Variables Group A (n=275) Group B (n=275 p-value
n (%) n (%)
Age:
<20-30 years 173 (62.9) 179 (65.1) 0.59
31->40 years 102 (37) 96 (34)
Mode of delivery:
Vaginal 152 (55.3) 125 (45.5) 0.02
Caesarean section 123 (44.7) 150 (54.5)
Parity:
Primiparous 105 (38.2) 118 (42.9) 0.25
Multiparous 170 (61.8) 157 (57.1)
Family history of GDM:
Yes 156 (56.9) 184 (66.9) 0.01
No 119 (43.1) 91 (33.1)
History of GDM:
Yes 27 (32.1) 35 (43.8) 0.12
No 57 (67.9) 45 (56.3)
Gestational age at delivery:
< 37 weeks 24 (8.7) 24 (8.7) 1.00
37-40 weeks 251 (91.3) 251 (91.3)
Antenatal sugar control method:
Diet
Metformin 138 (50.2) 88 (32) 0.00
Insulin with/without Metofrmin 108 (39.3) 158 (57.5)
First visit postpartum:
Yes 219 (79.6) 236 (85.8) 0.05
No 56 (20.4) 39 (14.2)
Second visit postpartum:
Yes 66 (52.8) 59 (21.5) 0.47
No 209 (76) 216 (78.5)
GDM: Gestational diabetes mellitus
Table-1: Baseline characteristics of pre intervention and post intervention group
Variables Advice for postpartum OGTT Crude OR Adjusted OR
No [n (%)] Yes [n (%)] (95% C.I) (95% C.I)
Group A 199 (72.4) 76 (27.6) 1 1
Group B 135 (49.1) 140 (50.9) 2.71 (1.90, 3.87) 3.34 (1.43, 7.83)
Family history of DM:
No 138 (66) 71 (34) 1 1
Yes 195 (57.4) 145 (42.6) 1.44 (1.01, 2.06) 1.90 (.79, 4.61)
History of GDM:
No 77 (75.5) 25 (24.5) 1 1
Yes 41 (66.1) 21 (33.9) 1.57 (.78, 3.15) .70 (.30, 1.63)
Mode of delivery:
Vaginal 192 (69.3) 85 (30.7) 1 1
Cesarean section 142 (52) 131 (48) 2.08 (1.47, 2.95) 3.94 (1.70, 9.10)
Antenatal sugar control method:
Diet 170 (75.2) 56 (24.8) 1 1
Metformin 137 (51.5) 129 (48.5) 2.85 (1.94, 4.20) 3.95 (1.58, 9.85)
Insulin with/without metofrmin 27 (46.6) 31 (53.4) 3.48 (1.91, 6.33) 4.14 (1.00, 17.09)
Employee status:
Full time 287 (59.3) 197 (40.7) 1 1
Part time 47 (71.2) 19 (28.8) 1.69 (.96, 2.98) 6.85 (1.33, 35.16)
OGTT: Oral glucose tolerance test, OR: Odds ratio, CI: Confidence interval.
Table-2: Factors associated with physician's advice for OGTT during postpartum period (n=550).
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